|
Description:
|
|
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing.
Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell
Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer Center
Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology. |